Lessons from the marine census

Now that the ten-year effort to take stock of the diversity of life in the oceans came to a triumphant end late last year, researchers involved in the Census for Marine Life are reflecting on the project's shortcomings.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

School master snapperAYESHA CANTRELL / DREAMSTIME.COM

Now that the ten-year effort to take stock of the diversity of life in the oceans came to a triumphant end late last year, researchers involved in the Census for Marine Life are reflecting on the project's shortcomings. Of main concern is the future of the project, which cost around $635 million, now that the funding has ended, stressing the lack of "procedures for bringing forward new leaders to continue the projects," Nature reports. The review was commissioned by the Alfred P. Sloan Foundation, the main funder of the census, and will be presented in draft form today (May 19).

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Cristina Luiggi

    This person does not yet have a bio.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development